• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LRP/LR 的敲除影响晚期结直肠癌细胞中的信号通路。

Knock-down of LRP/LR influences signalling pathways in late-stage colorectal carcinoma cells.

机构信息

School of Molecular and Cell Biology, University of the Witwatersrand, Private Bag 3, Wits 2050, Johannesburg, Republic of South Africa.

出版信息

BMC Cancer. 2021 Apr 9;21(1):392. doi: 10.1186/s12885-021-08081-3.

DOI:10.1186/s12885-021-08081-3
PMID:33836696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8035741/
Abstract

BACKGROUND

The 37 kDa/67 kDa laminin receptor (LRP/LR) is involved in several tumourigenic-promoting processes including cellular viability maintenance and apoptotic evasion. Thus, the aim of this study was to assess the molecular mechanism of LRP/LR on apoptotic pathways in late stage (DLD-1) colorectal cancer cells upon siRNA-mediated down-regulation of LRP/LR.

METHODS

siRNAs were used to down-regulate the expression of LRP/LR in DLD-1 cells which was assessed using western blotting and qPCR. To evaluate the mechanistic role of LRP/LR, proteomic analysis of pathways involved in proliferation and apoptosis were investigated. The data from the study was analysed using a one-way ANOVA, followed by a two-tailed student's t-test with a confidence interval of 95%.

RESULTS

Here we show that knock-down of LRP/LR led to significant changes in the proteome of DLD-1 cells, exposing new roles of the protein. Moreover, analysis showed that LRP/LR may alter components of the MAPK, p53-apoptotic and autophagic signalling pathways to aid colorectal cancer cells in continuous growth and survival. Knock-down of LRP/LR also resulted in significant decreases in telomerase activity and telomerase-related proteins in the DLD-1 cells.

CONCLUSIONS

These findings show that LRP/LR is critically implicated in apoptosis and cell viability maintenance and suggest that siRNA-mediated knock-down of LRP/LR may be a possible therapeutic strategy for the treatment of colorectal cancer.

摘要

背景

37kDa/67kDa 层粘连蛋白受体(LRP/LR)参与多种促进肿瘤发生的过程,包括细胞存活维持和凋亡逃逸。因此,本研究旨在评估 LRP/LR 在晚期(DLD-1)结直肠癌细胞中通过 siRNA 介导的 LRP/LR 下调对细胞凋亡途径的分子机制。

方法

使用 siRNA 下调 DLD-1 细胞中 LRP/LR 的表达,使用 Western blot 和 qPCR 进行评估。为了评估 LRP/LR 的机制作用,研究了参与增殖和凋亡的途径的蛋白质组学分析。使用单向方差分析对研究数据进行分析,然后使用置信区间为 95%的双尾学生 t 检验进行检验。

结果

我们发现,LRP/LR 的敲低导致 DLD-1 细胞的蛋白质组发生显著变化,揭示了该蛋白的新作用。此外,分析表明,LRP/LR 可能改变 MAPK、p53 凋亡和自噬信号通路的成分,以帮助结直肠癌细胞持续生长和存活。LRP/LR 的敲低还导致 DLD-1 细胞中端粒酶活性和端粒酶相关蛋白的显著降低。

结论

这些发现表明 LRP/LR 对细胞凋亡和细胞存活维持至关重要,并表明 siRNA 介导的 LRP/LR 敲低可能是治疗结直肠癌的一种潜在治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730d/8035741/ba1f93410a17/12885_2021_8081_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730d/8035741/19bcceefb995/12885_2021_8081_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730d/8035741/27e281be2bd9/12885_2021_8081_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730d/8035741/342d8f18e143/12885_2021_8081_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730d/8035741/8d08e5465ae1/12885_2021_8081_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730d/8035741/ba1f93410a17/12885_2021_8081_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730d/8035741/19bcceefb995/12885_2021_8081_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730d/8035741/27e281be2bd9/12885_2021_8081_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730d/8035741/342d8f18e143/12885_2021_8081_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730d/8035741/8d08e5465ae1/12885_2021_8081_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730d/8035741/ba1f93410a17/12885_2021_8081_Fig5_HTML.jpg

相似文献

1
Knock-down of LRP/LR influences signalling pathways in late-stage colorectal carcinoma cells.LRP/LR 的敲除影响晚期结直肠癌细胞中的信号通路。
BMC Cancer. 2021 Apr 9;21(1):392. doi: 10.1186/s12885-021-08081-3.
2
Knock-down of LRP/LR promotes apoptosis in early and late stage colorectal carcinoma cells via caspase activation.LRP/LR 敲低通过半胱天冬酶激活促进结直肠癌细胞的早晚期凋亡。
BMC Cancer. 2018 May 29;18(1):602. doi: 10.1186/s12885-018-4531-2.
3
siRNA - Mediated LRP/LR knock-down reduces cellular viability of malignant melanoma cells through the activation of apoptotic caspases.siRNA 介导的 LRP/LR 敲低通过激活凋亡半胱氨酸蛋白酶降低恶性黑素瘤细胞的细胞活力。
Exp Cell Res. 2018 Jul 1;368(1):1-12. doi: 10.1016/j.yexcr.2018.04.003. Epub 2018 Apr 10.
4
Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells.用 siRNA 下调 LRP/LR 抑制肺癌细胞中的多个癌症特征。
FEBS Open Bio. 2023 Feb;13(2):323-340. doi: 10.1002/2211-5463.13544. Epub 2023 Jan 13.
5
Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity.敲低37kDa/67kDa层粘连蛋白受体LRP/LR会阻碍端粒酶活性。
PLoS One. 2015 Nov 6;10(11):e0141618. doi: 10.1371/journal.pone.0141618. eCollection 2015.
6
Knockdown of LRP/LR induces apoptosis in pancreatic cancer and neuroblastoma cells through activation of caspases.敲低低密度脂蛋白受体相关蛋白/LRP通过激活半胱天冬酶诱导胰腺癌和神经母细胞瘤细胞凋亡。
Exp Cell Res. 2017 Nov 15;360(2):264-272. doi: 10.1016/j.yexcr.2017.09.016. Epub 2017 Sep 10.
7
Downregulation of the non-integrin laminin receptor reduces cellular viability by inducing apoptosis in lung and cervical cancer cells.层粘连蛋白非整联受体下调通过诱导肺癌和宫颈癌细胞凋亡来降低细胞活力。
PLoS One. 2013;8(3):e57409. doi: 10.1371/journal.pone.0057409. Epub 2013 Mar 5.
8
Knockdown of LRP/LR Induces Apoptosis in Breast and Oesophageal Cancer Cells.LRP/LR 基因敲低诱导乳腺癌和食管癌细胞凋亡。
PLoS One. 2015 Oct 1;10(10):e0139584. doi: 10.1371/journal.pone.0139584. eCollection 2015.
9
Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicity.抗LRP/LR特异性抗体IgG1-iS18以及通过短发夹RNA(shRNAs)敲低LRP/LR可使细胞免受Aβ42诱导的细胞毒性作用。
Sci Rep. 2013;3:2702. doi: 10.1038/srep02702.
10
IgG1-iS18 impedes the adhesive and invasive potential of early and late stage malignant melanoma cells.IgG1-iS18可抑制早期和晚期恶性黑色素瘤细胞的黏附及侵袭能力。
Exp Cell Res. 2017 Feb 15;351(2):135-141. doi: 10.1016/j.yexcr.2017.01.009. Epub 2017 Jan 22.

引用本文的文献

1
PLGA nanocapsules as a delivery system for a recombinant LRP-based therapeutic.PLGA 纳米胶囊作为基于 LRP 的重组治疗药物的递送系统。
FEBS Open Bio. 2024 Jul;14(7):1072-1086. doi: 10.1002/2211-5463.13809. Epub 2024 May 3.
2
Emerging roles of the cellular prion protein (PrP) and 37/67 kDa laminin receptor (RPSA) interaction in cancer biology.细胞朊蛋白(PrP)和 37/67 kDa 层粘连蛋白受体(RPSA)相互作用在癌症生物学中的新作用。
Cell Mol Life Sci. 2023 Jul 15;80(8):207. doi: 10.1007/s00018-023-04844-2.
3
Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells.

本文引用的文献

1
Patented therapeutic approaches targeting LRP/LR for cancer treatment.针对癌症治疗的 LRP/LR 的专利治疗方法。
Expert Opin Ther Pat. 2019 Dec;29(12):987-1009. doi: 10.1080/13543776.2019.1693543. Epub 2019 Nov 20.
2
Telomerase Reverse Transcriptase (TERT) in Action: Cross-Talking with Epigenetics.端粒酶逆转录酶(TERT)的作用:与表观遗传学的交叉对话。
Int J Mol Sci. 2019 Jul 7;20(13):3338. doi: 10.3390/ijms20133338.
3
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
用 siRNA 下调 LRP/LR 抑制肺癌细胞中的多个癌症特征。
FEBS Open Bio. 2023 Feb;13(2):323-340. doi: 10.1002/2211-5463.13544. Epub 2023 Jan 13.
全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
4
Data-independent acquisition-based SWATH-MS for quantitative proteomics: a tutorial.基于数据非依赖采集的 SWATH-MS 在定量蛋白质组学中的应用:教程。
Mol Syst Biol. 2018 Aug 13;14(8):e8126. doi: 10.15252/msb.20178126.
5
Knock-down of LRP/LR promotes apoptosis in early and late stage colorectal carcinoma cells via caspase activation.LRP/LR 敲低通过半胱天冬酶激活促进结直肠癌细胞的早晚期凋亡。
BMC Cancer. 2018 May 29;18(1):602. doi: 10.1186/s12885-018-4531-2.
6
siRNA - Mediated LRP/LR knock-down reduces cellular viability of malignant melanoma cells through the activation of apoptotic caspases.siRNA 介导的 LRP/LR 敲低通过激活凋亡半胱氨酸蛋白酶降低恶性黑素瘤细胞的细胞活力。
Exp Cell Res. 2018 Jul 1;368(1):1-12. doi: 10.1016/j.yexcr.2018.04.003. Epub 2018 Apr 10.
7
37 kDa LRP::FLAG enhances telomerase activity and reduces senescent markers .37千道尔顿的低密度脂蛋白受体相关蛋白(LRP)::FLAG增强端粒酶活性并减少衰老标志物 。
Oncotarget. 2017 Sep 27;8(49):86646-86656. doi: 10.18632/oncotarget.21278. eCollection 2017 Oct 17.
8
Knockdown of LRP/LR induces apoptosis in pancreatic cancer and neuroblastoma cells through activation of caspases.敲低低密度脂蛋白受体相关蛋白/LRP通过激活半胱天冬酶诱导胰腺癌和神经母细胞瘤细胞凋亡。
Exp Cell Res. 2017 Nov 15;360(2):264-272. doi: 10.1016/j.yexcr.2017.09.016. Epub 2017 Sep 10.
9
Telomeres in cancer: tumour suppression and genome instability.癌症中的端粒:肿瘤抑制与基因组不稳定
Nat Rev Mol Cell Biol. 2017 Mar;18(3):175-186. doi: 10.1038/nrm.2016.171. Epub 2017 Jan 18.
10
Anti-LRP/LR-specific antibody IgG1-iS18 impedes adhesion and invasion of pancreatic cancer and neuroblastoma cells.抗LRP/LR特异性抗体IgG1-iS18可抑制胰腺癌细胞和神经母细胞瘤细胞的黏附与侵袭。
BMC Cancer. 2016 Nov 24;16(1):917. doi: 10.1186/s12885-016-2953-2.